Perkins Capital Management’s BioTelemetry, Inc. BEAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-32,535
| Closed | -$2.35M | – | 114 |
|
|
2020
Q4 | $2.35M | Sell |
32,535
-1,700
| -5% | -$89K | 1.53% | 18 |
|
|
2020
Q3 | $1.56M | Buy |
+34,235
| New | +$1.43M | 1.43% | 27 |
|
|
2020
Q1 | $1.49M | Buy |
38,735
+15,285
| +65% | +$704K | 1.8% | 20 |
|
|
2019
Q4 | $1.09M | Buy |
23,450
+8,450
| +56% | +$366K | 0.97% | 35 |
|
|
2019
Q3 | $611K | Hold |
15,000
| – | – | 0.53% | 61 |
|
|
2019
Q2 | $722K | Hold |
15,000
| – | – | 0.51% | 59 |
|
|
2019
Q1 | $939K | Hold |
15,000
| – | – | 0.62% | 50 |
|
|
2018
Q4 | $896K | Hold |
15,000
| – | – | 0.69% | 44 |
|
|
2018
Q3 | $967K | Hold |
15,000
| – | – | 0.58% | 57 |
|
|
2018
Q2 | $675K | Hold |
15,000
| – | – | 0.48% | 66 |
|
|
2018
Q1 | $466K | Hold |
15,000
| – | – | 0.42% | 69 |
|
|
2017
Q4 | $449K | Hold |
15,000
| – | – | 0.43% | 68 |
|
|
2017
Q3 | $495K | Hold |
15,000
| – | – | 0.52% | 59 |
|
|
2017
Q2 | $502K | Hold |
15,000
| – | – | 0.56% | 56 |
|
|
2017
Q1 | $434K | Hold |
15,000
| – | – | 0.45% | 71 |
|
|
2016
Q4 | $335K | Hold |
15,000
| – | – | 0.37% | 75 |
|
|
2016
Q3 | $279K | Sell |
15,000
-105,250
| -88% | -$1.98M | 0.28% | 83 |
|
|
2016
Q2 | $1.96M | Hold |
120,250
| – | – | 2.25% | 8 |
|
|
2016
Q1 | $1.41M | Buy |
120,250
+1,200
| +1% | +$13.4K | 1.76% | 13 |
|
|
2015
Q4 | $1.39M | Buy |
119,050
+25,600
| +27% | +$324K | 1.49% | 18 |
|
|
2015
Q3 | $1.14M | Buy |
+93,450
| New | +$1.19M | 1.27% | 22 |
|
|
2014
Q1 | – | Sell |
-24,800
| Closed | -$197K | – | 152 |
|
|
2013
Q4 | $197K | Sell |
24,800
-148,279
| -86% | -$1.38M | 0.13% | 114 |
|
|
2013
Q3 | $1.72M | Sell |
173,079
-414,739
| -71% | -$3.26M | 1.23% | 27 |
|
|
2013
Q2 | $3.47M | Buy |
+587,818
| New | +$1.98M | 2.75% | 4 |
|
Other funds holding BEAT
Perkins Capital Management's BEAT Position: Q1 2021 in Review
Perkins Capital Management sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 32,535 shares — an estimated $2.35M sold.
Perkins Capital Management first reported a position in BEAT in Q2 2013 and held it in 24 quarters. The position peaked at $3.47M in Q2 2013. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.
- Perkins Capital Management reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
- Perkins Capital Management sold 32,535 BioTelemetry, Inc. shares in Q1 2021, an estimated $2.35M.
- Perkins Capital Management first reported a position in BioTelemetry, Inc. in Q2 2013 and held it in 24 quarters.
- Perkins Capital Management's BioTelemetry, Inc. position peaked at $3.47M in Q2 2013.
- 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.
Based on Perkins Capital Management's 13F filing for Q1 2021, filed 28 Apr 2021.